Midland Daily News on MSN

Savvy Senior: How to create a digital will and protect online accounts

In addition to creating an estate plan, you should also make a “digital will” that lists all your online accounts and login ...

Earlier use of CARVYKTI® (ciltacabtagene autoleucel) demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma

Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single infusion as early as second line1 Data suggest ...